Clinical Trials Logo

Clinical Trial Summary

Sodium fluorescein, which has been shown to be useful for intraoperative guidance regarding the resection of adult neurosurgical tumors, can aid the resection of pediatric neurosurgical tumors.


Clinical Trial Description

This study will be a prospective non-randomized cohort study with patients presenting to Children's Hospital Colorado for resection of a central nervous system tumor. This study will employ the use of sodium fluorescein and an FDA approved operative microscope equipped with excitation and barrier filters for monitoring with sufficient fluorescent enhancement and contrast. Fluorescein sodium is a small organic salt that accumulates in areas of diminished blood-brain barrier integrity and allows for determination of the margins between tumor and normal brain function. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT03752203
Study type Interventional
Source University of Colorado, Denver
Contact
Status Terminated
Phase N/A
Start date August 11, 2021
Completion date June 29, 2023